Bambusa Therapeutics, Inc. (Bambusa Therapeutics), a clinical-stage biotechnology company pioneering next-generation ...

Asking briefly about signs and symptoms of asthma allows clinicians to find unrecognized cases even in a community with an ...

Giredestrant plus Afinitor improved survival without progression in ER-positive advanced breast cancer. Phase 3 study results show that giredestrant significantly improved survival without tumor ...

A new study confirms ICD-10 code L80's high accuracy in identifying vitiligo, especially when combined with treatment data, enhancing clinical research.

Dr Daniel Petrylak discusses groundbreaking advancements in prostate cancer treatment, including genetic mutations, PARP ...

Emergency presentations (EPs) in colorectal cancer (CRC) are common and associated with worse outcomes; many are potentially ...

United Therapeutics recently announced positive results from its pivotal Phase 3 TETON-2 study, showing that nebulized Tyvaso significantly improved lung function in patients with idiopathic pulmonary ...

The FDA has approved a new subcutaneous (SC) formulation of pembrolizumab (Keytruda Qlex), co-formulated with ...

The AAP recommends that pediatric providers screen children beginning at age 6 months to identify early signs of mental, ...

Mohiuddin said voices of the autistic community should come first when establishing priorities for research and treatment.

As one of Louisiana’s leading biomedical research institutions, LSU Health New Orleans has announced the award of two federal ...

Allogene Therapeutics, Inc. ( NASDAQ: ALLO) Citi's SMID Call Series 2025 October 2, 2025 1:00 PM EDT ...